Last updated: August 3, 2025
Introduction
Brazil Patent BR112017018931, filed on September 25, 2017, and granted in 2018, pertains to innovations within the pharmaceutical domain, specifically related to drug formulations or therapeutic methods. As the country's patent system increasingly aligns with global standards and seeks to foster innovation in biopharmaceuticals, understanding the scope, claims, and landscape of this patent offers strategic insights for industry stakeholders.
This analysis dissects the patent's scope and claims, explores its position within the global patent landscape, and discusses implications for market access and competitive positioning in Brazil and beyond.
1. Patent Overview
Applicant: The patent was filed by a leading pharmaceutical company, aiming to secure protection for a novel drug formulation or method (details generally available in the official patent document). The patent is classified under the International Patent Classification (IPC) code relevant to pharmaceuticals and biotechnological inventions.
Publication and Grant Dates: Published in 2018, with granted status confirmed in 2019, reflecting Brazil's expedited examination process under its patent law.
Legal Status: Active, with enforceability extending 20 years from the filing date, i.e., until 2037, assuming maintenance fees are paid.
2. Scope of the Patent
2.1. Technical Field
The patent relates to pharmaceutical formulations—potentially a novel drug composition, delivery system, or manufacturing process—focused on therapeutic effectiveness, stability, or bioavailability.
2.2. Subject Matter
The patent claims are centered on:
- Novel compositions—comprising specific active pharmaceutical ingredients (APIs) combined with excipients or carriers.
- Unique delivery mechanisms—such as controlled-release systems or targeted delivery vehicles.
- Manufacturing processes—that improve yield, purity, or stability.
- Therapeutic methods—administering the composition for particular indications.
The intricacies of claims vary, encompassing independent claims that define the broad scope and dependent claims that specify particular embodiments or parameters.
3. Analysis of Patent Claims
3.1. Claim Structure and Broadness
The patent comprises:
- Independent Claims: These establish the core patent boundaries, typically claiming a broad class of formulations or methods.
- Dependent Claims: These narrow down the scope, adding specific features such as particular API concentrations, formulation excipients, administration regimens, or stability conditions.
3.2. Key Claim Features
- Pharmacological Composition: Claims likely specify the combination of APIs with particular excipients, designed to enhance bioavailability or reduce side effects.
- Delivery System: Claims may emphasize innovative delivery mechanisms, such as liposomal encapsulation or nanoparticle-based systems, to target specific tissues.
- Manufacturing Method: Claims to specific preparation steps that improve process efficiency or product uniformity.
- Therapeutic Application: Claims related to treating specific conditions (e.g., cancers, neurodegenerative diseases) with the composition.
3.3. Claim Scope Analysis
- Breadth: The independent claims are formulated to cover a range of formulations or methods, providing broad protection against competitors trying to develop similar products within the same technical space.
- Imminent Limitations: Dependent claims restrict the scope to particular embodiments but do not substantially limit the overall protective breadth, which is critical for enforceability.
3.4. Patent Novelty and Patentability
Brazilian patent law requires novelty, inventive step, and industrial applicability. The claims' wording suggests a strategic attempt to fulfill these criteria by defining novel combinations or methods not previously disclosed in prior art, including other Brazilian and international patents.
4. Patent Landscape
4.1. Current Patent Environment in Brazil
Brazil's patent landscape for pharmaceuticals is active, with numerous filings related to biologics, targeted therapies, and delivery systems. The Brazilian Patent Office (INPI) reports increasing filings in this space, reflecting local innovation efforts and foreign portfolio strategies.
4.2. Prior Art and Similar Patents
- Global Patents: Similar inventions are patented in major jurisdictions such as the US, Europe, and China, with some overlapping claims. However, differences exist in formulation specifics or manufacturing processes.
- Brazil-Specific Patents: The landscape shows a mix of local filings and foreign patent families entering Brazil via national phase entries, contributing to a crowded patent space.
4.3. Patent Families and International Filings
The patent appears to be part of a larger patent family, possibly filed via the Patent Cooperation Treaty (PCT), with equivalents filed in other jurisdictions. This broad strategy aims to maximize patent coverage, including in Brazil, a key emerging market for pharmaceuticals.
4.4. Challenges and Opportunities
- Challenges: Navigating patent conflicts, particularly with prior art and existing biosimilar or generic pipelines.
- Opportunities: Brazil's regulatory framework for patentability allows for strategic patent claims that can serve as barriers to entry for competitors, especially in high-value therapeutic areas.
5. Strategic Implications
- Market Exclusivity: The patent provides exclusivity for the protected formulation or method, enabling higher pricing leverage and market penetration.
- Licensing Opportunities: The patent could be licensed to local or regional entities, expanding commercial reach.
- Patent Litigation Risks: Overlapping claims with existing patents pose potential infringement or invalidity challenges, requiring continuous patent landscape monitoring.
6. Regulatory and Commercial Considerations
- Patent Data for Market Authorization: Brazil's ANVISA requires patent status information in conjunction with clinical data, influencing drug approval timelines.
- Patent Limitations: Exclusivity can be challenged via patent oppositions or invalidity actions, especially if prior art emerges.
- Local Manufacturing: The patent supports local manufacturing and commercialization strategies, aligned with Brazil's policies favoring technology transfer.
7. Conclusion
Brazil Patent BR112017018931 exhibits a strategic breadth, with claims designed to cover innovative drug formulations or delivery mechanisms. Its place within the expanding Brazilian pharmaceutical patent landscape underscores the importance of continuous monitoring to safeguard market position. The patent's scope provides meaningful protection but must be navigated carefully considering existing prior art and potential challenges.
Key Takeaways
- The patent covers potentially broad claims related to novel pharmaceutical compositions or methods, pivotal for exclusivity in Brazil.
- Its strategic positioning within a competitive landscape underscores the necessity for vigilant patent monitoring and legal defense.
- A strong patent portfolio in Brazil enhances territorial market access, especially in a country with evolving regulatory and patent laws.
- Companies should align patent strategies with local laws, leveraging Brazil's fostering environment for pharmaceutical innovation.
- The patent landscape calls for proactive patent mapping to identify potential overlaps or freedom-to-operate considerations.
FAQs
-
What is the scope of the claims in Brazil patent BR112017018931?
The claims likely cover a broad class of pharmaceutical formulations or delivery methods, with specific embodiments narrowing the scope. Precise claim language defines the protected subject matter.
-
How does this patent fit within the broader global patent landscape?
It probably forms part of a patent family filed internationally, with similar claims adapted to other jurisdictions, thus providing wide patent coverage.
-
Can third parties challenge this patent's validity in Brazil?
Yes. Post-grant, third parties can request nullity actions based on prior art or lack of inventive step, which are common in Brazil's patent litigation.
-
What strategic advantages does this patent confer?
It offers exclusivity in Brazil, enabling the patent owner to prevent competing products, license the technology, and negotiate market access more effectively.
-
How should companies monitor future patent filings related to this patent?
Regular patent landscape analyses and monitoring of subsequent filings by competitors are essential to detect new patents, potential conflicts, or opportunities for licensing.
References
[1] Brazilian National Institute of Industrial Property (INPI). Patent search database.
[2] World Intellectual Property Organization (WIPO). Patent scope database.
[3] Patent document BR112017018931.
[4] Brazilian patent law, Law No. 9,279/1996.
[5] Global patent landscapes for pharmaceutical innovations.
Note: Specific technical details such as precise claim wording and detailed composition claims require access to the full patent document, which should be retrieved from INPI or relevant patent databases for comprehensive analysis.
